Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPD

Stopped Recruitment was temporarily suspended pending additional funding and activation of additional study centers. The pilot phase has been completed and is currently being evaluated. The suspension was not related to safety concerns.

Conditions

• COPD (Chronic Obstructive Pulmonary Disease)

Interventions

• DRUG: Tiotropium
• DRUG: Olodaterol
• DRUG: Umeclidinium
• DRUG: Vilanterol
• DRUG: Indacaterol
• DRUG: Glycopyrronium

Sponsor

Medical University of Bialystok